- ￥400
- gemig
- XF-J4431
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格：
10mg
产品货号：XF-J4431
产品规格：10mg
产品包装：瓶
储存条件及有效期：详见标签
本产品仅供科研实验用，不做其他用途！
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Treatment of Infections Caused by Resistant Staphylococcus aureus
up to February 2006. Despite the emergence of resistant and multidrug resistant S. aureus , five effective drugs for which little resistance has been observed are in clinical use: vancomycin, quinupristin-dalfopristin, linezolid, tigecycline, and daptomycin
Treatment of Infections Due to Resistant Staphylococcus aureus
up to January of 2013. Despite the emergence of resistant and multidrug-resistant S. aureus , we have seven effective drugs in clinical use for which little resistance has been observed: vancomycin, quinupristin–dalfopristin, linezolid, tigecycline, telavancin
Detecting Mutations That Confer Oxazolidinone Resistance in Gram-Positive Bacteria
Resistance to oxazolidinone antibiotics, including linezolid, in Gram-positive bacteria is mediated by single-nucleotide polymorphisms (SNPs) in the 23S ribosomal RNA. A G2576U change (encoded by a G2576T mutation in the rRNA genes
技术资料暂无技术资料 索取技术资料
